Assessment of Anticancer Drug Utilization Pattern from a hospital-based cancer registry—A Single Center Experience from Saudi Arabia

In recent years, various advancements in anticancer therapy have led to the development of multiple regimens and protocols. This study endeavors to provide an extensive evaluation of anticancer therapy prescription patterns from a hospital-based cancer registry.
Materials and Methods: From June 2014 to April 2022, 512 adult cancer patients who received chemotherapy in our cancer center were included in a retrospective study. Data encompassed demographic characteristics of patients and cancer, chemotherapy protocols or agents, antiemetics, and drug side effects. The prescribed drugs were assessed using the Essential Medicines List (EML), while the prescription’s rationality was determined using the World Health Organization (WHO) indicators.